Tranexamic Acid for Unilateral Total Knee Arthroplasty

Status Completed

Clinical Trial Summary

Total knee arthroplasty is often associated with excessive postoperative bleeding due to increased fibrinolysis. Hence, the objective of the proposed of this multicentre study is to determine the peri-operative bleeding comparing the application of topical and intravenous tranexamic acid with the habitual surgical haemostasis.

Clinical Trial Description

Objectives:

1. Principal: To assess if the topical and intravenous tranexamic acid reduce less or at least than 20% the blood losses with respect to the habitual haemostasia in patients, after unilateral total knee arthroplasty.

2. Secondary: To assess the treatment safety. To perform a cost- analyses.

Methods: Randomized, multicentre, open and parallel clinical trial with three comparative groups: Topical tranexamic acid, Intravenous tranexamic acid and habitual haemostasia. In all patients, a single drainage of 8mm will be inserted in the joint, and it will remain closed during one hour after the closure of the skin.

Nº of participant centres: 2. Random allocation will be centralised in "Hospital de la Santa Creu i Sant Pau".

Main outcome: Total blood loss (mL) in the post-operative period collected by the habitual drain system ).

Secondary outcomes: Total blood loss (mL)and hidden blood calculated by Nadler's formula. Proportion of patients with blood transfusion, complications of surgery wound, haemoglobin pre and post-operative, units of blood transfused, post-operative mortality, days of hospital stay, safety of interventions assessed.Direct cost analysis.

Substudy: Pharmacokinetic study. The first 24 patients included in "Hospital de la Santa Creu i Sant Pau" for tranexamic acid (12 topical- 12 intravenous) to determine:

1. Plasmatic concentrations of tranexamic acid

2. In topical and intravenous tranexamic acid administration determine the absorption rate and drug bioavailability by these routes: maximum plasma concentration, time to reach Cmax, AUC, and half-life. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01594671
Study type	Interventional
Source	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Contact
Status	Completed
Phase	Phase 3
Start date	February 2012
Completion date	October 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04588350` - Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery	N/A
Completed	`NCT05426564` - Exploratory Assessment of the Quantra® System in Adult ECMO Patients
Active, not recruiting	`NCT05492214` - The Effect of Time Window for Umbilical Cord Clamping During Cesareans on Offspring Hemoglobin and Maternal Blood Loss	N/A
Withdrawn	`NCT05518279` - Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures	Phase 3
Enrolling by invitation	`NCT02910115` - Cooling the Uterus in C-section After Dysfunctional Labor	N/A
Completed	`NCT02569658` - Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty	N/A
Completed	`NCT01048658` - Sevoflurane as an Anesthetic During Dilation and Evacuation Procedures	Phase 4
Terminated	`NCT02908516` - Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures	Phase 4
Completed	`NCT04089865` - Oral Versus Intravenous Tranexamic Acid	Phase 4
Recruiting	`NCT06403163` - Transfusion Surveillance in Anaesthesia
Recruiting	`NCT02265562` - Rectal Misoprostol and Blood Loss During Abdominal Hysterectomy	Phase 3
Completed	`NCT02083809` - Effects of Oxytocin on Bleeding Outcomes During Dilation and Evacuation	N/A
Completed	`NCT02312440` - Comparison of Topical and Intravenous Tranexamic Acid in Total Hip Arthroplasty	Phase 3
Completed	`NCT01895101` - The Effect on Blood Loss of Topical and Intravenous Tranexamic Acid in Cardiac Surgery Patients	Phase 4
Completed	`NCT00990288` - The Use of FLOSEAL to Reduce Bleeding in Total Knee Replacement Surgery	Phase 4
Completed	`NCT01099475` - Effect of Intermittent Pedicle Clamping on Hepatocellular Injury During Liver Surgery	N/A
Completed	`NCT03365999` - Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.	Phase 2
Recruiting	`NCT05550623` - Pneumatic Tourniquet Versus no Tourniquet in Transfemoral Amputation	N/A
Completed	`NCT05012202` - Validating a New Point-of-care Device for Estimation of Blood Count in Pregnant Women
Completed	`NCT02311309` - Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Tranexamic Acid for Unilateral Total Knee Arthroplasty — TRANEXTOP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms